Epithelioid Mesothelioma
5 clinical trials · Condition
◉ Watch Epithelioid Mesothelioma
| Record | Firm | Date |
|---|---|---|
| Mesothelin-Targeted Immunotoxin LMB-100 in Combination With Tofacitinib in Persons With Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and Other Mesothelin Expressing Solid Tumors (NCT04034238) | National Cancer Institute (NCI) | 2019-08-29 |
| Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma (NCT03228537) | National Cancer Institute (NCI) | 2018-07-16 |
| Pembrolizumab in Treating Patients With Malignant Mesothelioma (NCT02399371) | University of Chicago | 2015-03-31 |
| Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma (NCT01861301) | National Cancer Institute (NCI) | 2013-01-01 |
| Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma (NCT01064648) | National Cancer Institute (NCI) | 2010-03-15 |
Track Epithelioid Mesothelioma automatically
Every clearance here is in the API, with alerts when new ones post.